Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 490120, 10 pages
http://dx.doi.org/10.1155/2015/490120
Research Article

Elevated Plasma IL-38 Concentrations in Patients with Acute ST-Segment Elevation Myocardial Infarction and Their Dynamics after Reperfusion Treatment

1Laboratory of Cardiovascular Immunology, Institute of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
2Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China

Received 6 August 2015; Revised 30 November 2015; Accepted 3 December 2015

Academic Editor: Ronald Gladue

Copyright © 2015 Yucheng Zhong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. G. Frangogiannis and M. L. Entman, “Chemokines in myocardial ischemia,” Trends in Cardiovascular Medicine, vol. 15, no. 5, pp. 163–169, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. M. L. Lindsey, D. L. Mann, M. L. Entman, and F. G. Spinale, “Extracellular matrix remodeling following myocardial injury,” Annals of Medicine, vol. 35, no. 5, pp. 316–326, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. N. G. Frangogiannis, C. W. Smith, and M. L. Entman, “The inflammatory response in myocardial infarction,” Cardiovascular Research, vol. 53, no. 1, pp. 31–47, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. N. G. Frangogiannis, “The immune system and cardiac repair,” Pharmacological Research, vol. 58, no. 2, pp. 88–111, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. K. O. Pietila, A. P. Harmoinen, J. Jokiniitty, and A. I. Pasternack, “Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment,” European Heart Journal, vol. 17, no. 9, pp. 1345–1349, 1996. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Lindmark, E. Diderholm, L. Wallentin, and A. Siegbahn, “Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy,” The Journal of the American Medical Association, vol. 286, no. 17, pp. 2107–2113, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Heeschen, S. Dimmeler, C. W. Hamm et al., “Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes,” Circulation, vol. 107, no. 16, pp. 2109–2114, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. G. De Luca, H. Suryapranata, F. Zijlstra et al., “Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty,” Journal of the American College of Cardiology, vol. 42, no. 6, pp. 991–997, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. G. De Luca, H. Suryapranata, J. P. Ottervanger, and E. M. Antman, “Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts,” Circulation, vol. 109, no. 10, pp. 1223–1225, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Pietilä, A. Harmoinen, W. Hermens, M. L. Simoons, F. Van de Werf, and M. Verstraete, “Serum C-reactive protein and infarct size in myocardial infarct patients with a closed versus an open infarct-related coronary artery after thrombolytic therapy,” European Heart Journal, vol. 14, no. 7, pp. 915–919, 1993. View at Publisher · View at Google Scholar · View at Scopus
  11. J. T. Bensen, P. A. Dawson, J. C. Mychaleckyj, and D. W. Bowden, “Identification of a novel human cytokine gene in the interleukin gene cluster on chromosome 2q12-14,” Journal of Interferon and Cytokine Research, vol. 21, no. 11, pp. 899–904, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Lin, A. S. Ho, D. Haley-Vicente et al., “Cloning and characterization of IL-1HY2, a novel interleukin-1 family member,” The Journal of Biological Chemistry, vol. 276, no. 23, pp. 20597–20602, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. F. L. van de Veerdonk, A. K. Stoeckman, G. Wu et al., “IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 8, pp. 3001–3005, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Dehghan, J. Dupuis, and M. Barbalic, “Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels,” Circulation, vol. 123, no. 7, pp. 731–738, 2011. View at Google Scholar
  15. M. Sabater-Lleal, J. Huang, D. Chasman et al., “Multiethnic meta-analysis of genome-wide association studies in >100 000 subjects identifies 23 fibrinogen-associated loci but no strong evidence of a causal association between circulating fibrinogen and cardiovascular disease,” Circulation, vol. 128, no. 12, pp. 1310–1324, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. H. C. Jha, P. Srivastava, H. Vardhan et al., “Chlamydia pneumoniae heat shock protein 60 is associated with apoptotic signaling pathway in human atheromatous plaques of coronary artery disease patients,” Journal of Cardiology, vol. 58, no. 3, pp. 216–225, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Van de Werf, J. Bax, A. Betriu et al., “Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology,” European Heart Journal, vol. 29, no. 23, pp. 2909–2945, 2008. View at Publisher · View at Google Scholar
  18. A. Dibra, J. Mehilli, M. Schwaiger et al., “Predictive value of basal C-reactive protein levels for myocardial salvage in patients with acute myocardial infarction is dependent on the type of reperfusion treatment,” European Heart Journal, vol. 24, no. 12, pp. 1128–1133, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Ozer, B. Tangurek, F. Firat et al., “Effects of drug-eluting stents on systemic inflammatory response in patients with unstable angina pectoris undergoing percutaneous coronary intervention,” Heart and Vessels, vol. 23, no. 2, pp. 75–82, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Yu, Q. Dong, X. Mao et al., “Disruption of the TSLP-TSLPR-LAP signaling between epithelial and dendritic cells through hyperlipidemia contributes to regulatory T-Cell defects in atherosclerotic mice,” Atherosclerosis, vol. 238, no. 2, pp. 278–288, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. B. I. Jugdutt, A. Jelani, A. Palaniyappan et al., “Aging-related early changes in markers of ventricular and matrix remodeling after reperfused st-segment elevation myocardial infarction in the canine model: effect of early therapy with an angiotensin II type 1 receptor blocker,” Circulation, vol. 122, no. 4, pp. 341–351, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. A. L. Pasqui, M. Di Renzo, G. Bova et al., “Pro-inflammatory/anti-inflammatory cytokine imbalance in acute coronary syndromes,” Clinical and Experimental Medicine, vol. 6, no. 1, pp. 38–44, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Lin, Y. Huang, Z. Lu et al., “Decreased plasma IL-35 levels are related to the left ventricular ejection fraction in coronary artery diseases,” PLoS ONE, vol. 7, no. 12, Article ID e52490, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. D. J. Grainger, P. R. Kemp, J. C. Metcalfe et al., “The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis,” Nature Medicine, vol. 1, no. 1, pp. 74–79, 1995. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Lin, A. S. Ho, D. Haley-Vicente et al., “Cloning and Characterization of IL-1HY2, a Novel Interleukin-1 Family Member,” The Journal of Biological Chemistry, vol. 276, no. 23, pp. 20597–20602, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. J.-C. Tardif, J.-F. Tanguay, S. S. Wright et al., “Effects of the P-selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention for non-ST-segment elevation myocardial infarction: results of the SELECT-ACS trial,” Journal of the American College of Cardiology, vol. 61, no. 20, pp. 2048–2055, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. C. del Fresno, L. Soler-Rangel, A. Soares-Schanoski et al., “Inflammatory responses associated with acute coronary syndrome up-regulate IRAK-M and induce endotoxin tolerance in circulating monocytes,” Journal of Endotoxin Research, vol. 13, no. 1, pp. 39–52, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. Q. Ji, Q. Zeng, Y. Huang et al., “Elevated plasma IL-37, IL-18, and IL-18BP concentrations in patients with acute coronary syndrome,” Mediators of Inflammation, vol. 2014, Article ID 165742, 9 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. M. L. Stadius, K. Davis, C. Maynard, J. L. Ritchie, and J. W. Kennedy, “Risk stratification for 1 year survival based on characteristics identified in the early hours of acute myocardial infarction. The Western Washington Intracoronary Streptokinase Trial,” Circulation, vol. 74, no. 4, pp. 703–711, 1986. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Göser, M. Andrassy, S. J. Buss et al., “Cardiac troponin I but not cardiac troponin T induces severe autoimmune inflammation in the myocardium,” Circulation, vol. 114, no. 16, pp. 1693–1702, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. J. A. de Lemos, D. K. McGuire, and M. H. Drazner, “B-type natriuretic peptide in cardiovascular disease,” The Lancet, vol. 362, no. 9380, pp. 316–322, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Talwar, I. B. Squire, P. F. Downie et al., “Profile of plasma N-terminal proBNP following acute myocardial infarction: correlation with left ventricular systolic dysfunction,” European Heart Journal, vol. 21, no. 18, pp. 1514–1521, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Morita, H. Yasue, M. Yoshimura et al., “Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction,” Circulation, vol. 88, no. 1, pp. 82–91, 1993. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Omland, A. Aakvaag, V. V. S. Bonarjee et al., “Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide,” Circulation, vol. 93, no. 11, pp. 1963–1969, 1996. View at Publisher · View at Google Scholar · View at Scopus
  35. F. Andreotti, D. R. Hackett, A. W. Haider et al., “Von willebrand factor, plasminogen activator inhibitor-1 and C-reactive protein are markers of thrombolytic efficacy in acute myocardial infarction,” Thrombosis and Haemostasis, vol. 68, no. 6, pp. 678–682, 1992. View at Google Scholar · View at Scopus
  36. T. Anzai, T. Yoshikawa, H. Shiraki et al., “C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction,” Circulation, vol. 96, no. 3, pp. 778–784, 1997. View at Publisher · View at Google Scholar · View at Scopus